ArticleObesity facts2021

Canagliflozin: A New Therapeutic Option in Patients That Present Postprandial Hyperinsulinemic Hypoglycemia after Roux-en-Y Gastric Bypass: A Pilot Study.

Andreea Ciudin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.